TY - JOUR
T1 - Diospyrin, a bisnaphthoquinone
T2 - A novel inhibitor of type I DNA topoisomerase of Leishmania donovani
AU - Ray, Sutapa
AU - Hazra, Banasri
AU - Mittra, Bidyottam
AU - Das, Aditi
AU - Majumder, Hemanta K.
PY - 1998
Y1 - 1998
N2 - Diospyrin is a plant product that has significant inhibitory effect on the growth of Leishmania donovani promastigotes. This compound inhibits the catalytic activity of DNA topoisomerase I of the parasite. Like camptothecin, it induces topoisomerase I mediated DNA cleavage in vitro. Treatment of DNA with diospyrin before addition of topoisomerase I has no effect. Preincubation of topoisomerase I with diospyrin before the addition of DNA in the relaxation reaction increases this inhibition. Our results suggest that this bisnaphthoquinone compound exerts its inhibitory effect by binding with the enzyme and stabilizing the topoisomerase I-DNA 'cleavable complex.' Diospyrin is a specific inhibitor of the parasitic topoisomerase I. It does not inhibit type II topoisomerase of L. donovani and requires much higher concentrations to inhibit type I topoisomerase of calf thymus. The potent inhibitory effect of diospyrin on type I DNA topoisomerase from L. donovani can be exploited for rational drug design inhuman leishmaniasis.
AB - Diospyrin is a plant product that has significant inhibitory effect on the growth of Leishmania donovani promastigotes. This compound inhibits the catalytic activity of DNA topoisomerase I of the parasite. Like camptothecin, it induces topoisomerase I mediated DNA cleavage in vitro. Treatment of DNA with diospyrin before addition of topoisomerase I has no effect. Preincubation of topoisomerase I with diospyrin before the addition of DNA in the relaxation reaction increases this inhibition. Our results suggest that this bisnaphthoquinone compound exerts its inhibitory effect by binding with the enzyme and stabilizing the topoisomerase I-DNA 'cleavable complex.' Diospyrin is a specific inhibitor of the parasitic topoisomerase I. It does not inhibit type II topoisomerase of L. donovani and requires much higher concentrations to inhibit type I topoisomerase of calf thymus. The potent inhibitory effect of diospyrin on type I DNA topoisomerase from L. donovani can be exploited for rational drug design inhuman leishmaniasis.
UR - http://www.scopus.com/inward/record.url?scp=0032407673&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032407673&partnerID=8YFLogxK
U2 - 10.1124/mol.54.6.994
DO - 10.1124/mol.54.6.994
M3 - Article
C2 - 9855627
AN - SCOPUS:0032407673
SN - 0026-895X
VL - 54
SP - 994
EP - 999
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 6
ER -